CIK 0001936258
- Large accelerated filer
NewAmsterdam Pharma Co N.V.
Sign in to watch- Ticker
- NAMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Netherlands
- Entity type
- Operating
- Phone
- 35 206 2971
- Business address
- GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
- Former names
- NewAmsterdam Pharma Co B.V.
Securities
- NAMS Ordinary Shares Nasdaq
- NAMSW Warrant Nasdaq
- 4 Open-market sale Chief Accounting Officer sold 150,000 shares at $20.37 ($3,055,500)
- 4 Planned sale Chief Operating Officer sold 100,000 shares
- 4 Planned sale Chief Operating Officer sold 70,441 shares
- 4 Planned sale Chief Financial Officer sold 61,883 shares
- 4 Planned sale Chief Operating Officer sold 129,559 shares
- 4 Grant or award Director acquired 6,960 shares (grant or award)
- 4 Grant or award Director acquired 6,960 shares (grant or award)
- 4 Grant or award Director acquired 6,960 shares (grant or award)
- 4 Grant or award Director acquired 6,960 shares (grant or award)
- 4 Grant or award Director acquired 6,960 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 15,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 123,529 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 34,000 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 14,000 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 43,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 44,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 38,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 7 · 132 filings